Contact Us: 01282 426380
KM Financial Solutions | China’s Junshi Biosciences raises $394 mln after pricing IPO at bottom of range -sources
40531
post-template-default,single,single-post,postid-40531,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

China’s Junshi Biosciences raises $394 mln after pricing IPO at bottom of range -sources

16 Dec China’s Junshi Biosciences raises $394 mln after pricing IPO at bottom of range -sources

Posted at 09:32h in News by
0 Likes
Chinese biotech startup
Shanghai Junshi Biosciences Co Ltd has raised $394
million after pricing its Hong Kong initial public offering
(IPO) at the bottom of a marketed range, two people familiar
with the share sale said on Monday.

No Comments

Sorry, the comment form is closed at this time.